WE‐D‐I‐6B‐05: A Technique for Respiratory‐Gated Radiotherapy Treatment Verification with An EPID in Cine Mode

R. Berbeco, T. Neicu, E. Rietzel, G. Chen, S. Jiang

Research output: Contribution to journalArticle

Abstract

Purpose: Many clinics are performing respiratory‐gated treatment based on external surrogates. Verification of these treatments is very important for ensuring the delivery of the planned dose distribution. Method and Materials: We have developed a new technique for treatment verification using an Electronic Portal Imaging Device (EPID) in cine mode for gated 3D conformal therapy. Implanted radiopaque fiducial markers inside or near the target are required for this technique. The markers are contoured on the planning CT set, enabling us to create Digitally Reconstructed Radiographs (DRR's) for each treatment beam. During the treatment, a sequence of EPID images are acquired without disrupting the treatment. Implanted markers are visualized in the images and their positions in the beam's‐eye‐view are calculated off‐line and compared to the reference position by matching the field apertures in corresponding EPID and DRR images. The precision of the patient setup, the placement of the beam‐gating window, as well as the residual tumor motion can be assessed. This technique has been demonstrated in a case study, with three implanted markers. Results: For this patient, the intra‐fractional variation of all marker positions in the gating window has a 95% range of 4.8 mm in the SI direction (the primary axis of motion). This is about the same (5 mm) as the residual motion considered in the planning process. The inter‐fractional variation of the daily mean positions of the markers, which indicates the uncertainty in the setup procedure, is within +8.3/−4.5 mm (95% range) in the SI direction. Conclusion: The proposed technique will be used for gated treatment verification. The results of many cases will help us determine appropriate treatment margins for gating. Conflict of Interest: This work was supported, in part, by a grant from Varian Medical Systems, Inc.

Original languageEnglish (US)
Number of pages1
JournalMedical Physics
Volume32
Issue number6
DOIs
StatePublished - 2005

Fingerprint

Radiotherapy
Equipment and Supplies
Therapeutics
Fiducial Markers
Conflict of Interest
Organized Financing
Residual Neoplasm
Uncertainty

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

WE‐D‐I‐6B‐05 : A Technique for Respiratory‐Gated Radiotherapy Treatment Verification with An EPID in Cine Mode. / Berbeco, R.; Neicu, T.; Rietzel, E.; Chen, G.; Jiang, S.

In: Medical Physics, Vol. 32, No. 6, 2005.

Research output: Contribution to journalArticle

@article{b5cbeb9175f04f1fb37373915dacaa08,
title = "WE‐D‐I‐6B‐05: A Technique for Respiratory‐Gated Radiotherapy Treatment Verification with An EPID in Cine Mode",
abstract = "Purpose: Many clinics are performing respiratory‐gated treatment based on external surrogates. Verification of these treatments is very important for ensuring the delivery of the planned dose distribution. Method and Materials: We have developed a new technique for treatment verification using an Electronic Portal Imaging Device (EPID) in cine mode for gated 3D conformal therapy. Implanted radiopaque fiducial markers inside or near the target are required for this technique. The markers are contoured on the planning CT set, enabling us to create Digitally Reconstructed Radiographs (DRR's) for each treatment beam. During the treatment, a sequence of EPID images are acquired without disrupting the treatment. Implanted markers are visualized in the images and their positions in the beam's‐eye‐view are calculated off‐line and compared to the reference position by matching the field apertures in corresponding EPID and DRR images. The precision of the patient setup, the placement of the beam‐gating window, as well as the residual tumor motion can be assessed. This technique has been demonstrated in a case study, with three implanted markers. Results: For this patient, the intra‐fractional variation of all marker positions in the gating window has a 95{\%} range of 4.8 mm in the SI direction (the primary axis of motion). This is about the same (5 mm) as the residual motion considered in the planning process. The inter‐fractional variation of the daily mean positions of the markers, which indicates the uncertainty in the setup procedure, is within +8.3/−4.5 mm (95{\%} range) in the SI direction. Conclusion: The proposed technique will be used for gated treatment verification. The results of many cases will help us determine appropriate treatment margins for gating. Conflict of Interest: This work was supported, in part, by a grant from Varian Medical Systems, Inc.",
author = "R. Berbeco and T. Neicu and E. Rietzel and G. Chen and S. Jiang",
year = "2005",
doi = "10.1118/1.1998541",
language = "English (US)",
volume = "32",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - WE‐D‐I‐6B‐05

T2 - A Technique for Respiratory‐Gated Radiotherapy Treatment Verification with An EPID in Cine Mode

AU - Berbeco, R.

AU - Neicu, T.

AU - Rietzel, E.

AU - Chen, G.

AU - Jiang, S.

PY - 2005

Y1 - 2005

N2 - Purpose: Many clinics are performing respiratory‐gated treatment based on external surrogates. Verification of these treatments is very important for ensuring the delivery of the planned dose distribution. Method and Materials: We have developed a new technique for treatment verification using an Electronic Portal Imaging Device (EPID) in cine mode for gated 3D conformal therapy. Implanted radiopaque fiducial markers inside or near the target are required for this technique. The markers are contoured on the planning CT set, enabling us to create Digitally Reconstructed Radiographs (DRR's) for each treatment beam. During the treatment, a sequence of EPID images are acquired without disrupting the treatment. Implanted markers are visualized in the images and their positions in the beam's‐eye‐view are calculated off‐line and compared to the reference position by matching the field apertures in corresponding EPID and DRR images. The precision of the patient setup, the placement of the beam‐gating window, as well as the residual tumor motion can be assessed. This technique has been demonstrated in a case study, with three implanted markers. Results: For this patient, the intra‐fractional variation of all marker positions in the gating window has a 95% range of 4.8 mm in the SI direction (the primary axis of motion). This is about the same (5 mm) as the residual motion considered in the planning process. The inter‐fractional variation of the daily mean positions of the markers, which indicates the uncertainty in the setup procedure, is within +8.3/−4.5 mm (95% range) in the SI direction. Conclusion: The proposed technique will be used for gated treatment verification. The results of many cases will help us determine appropriate treatment margins for gating. Conflict of Interest: This work was supported, in part, by a grant from Varian Medical Systems, Inc.

AB - Purpose: Many clinics are performing respiratory‐gated treatment based on external surrogates. Verification of these treatments is very important for ensuring the delivery of the planned dose distribution. Method and Materials: We have developed a new technique for treatment verification using an Electronic Portal Imaging Device (EPID) in cine mode for gated 3D conformal therapy. Implanted radiopaque fiducial markers inside or near the target are required for this technique. The markers are contoured on the planning CT set, enabling us to create Digitally Reconstructed Radiographs (DRR's) for each treatment beam. During the treatment, a sequence of EPID images are acquired without disrupting the treatment. Implanted markers are visualized in the images and their positions in the beam's‐eye‐view are calculated off‐line and compared to the reference position by matching the field apertures in corresponding EPID and DRR images. The precision of the patient setup, the placement of the beam‐gating window, as well as the residual tumor motion can be assessed. This technique has been demonstrated in a case study, with three implanted markers. Results: For this patient, the intra‐fractional variation of all marker positions in the gating window has a 95% range of 4.8 mm in the SI direction (the primary axis of motion). This is about the same (5 mm) as the residual motion considered in the planning process. The inter‐fractional variation of the daily mean positions of the markers, which indicates the uncertainty in the setup procedure, is within +8.3/−4.5 mm (95% range) in the SI direction. Conclusion: The proposed technique will be used for gated treatment verification. The results of many cases will help us determine appropriate treatment margins for gating. Conflict of Interest: This work was supported, in part, by a grant from Varian Medical Systems, Inc.

UR - http://www.scopus.com/inward/record.url?scp=85024810589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024810589&partnerID=8YFLogxK

U2 - 10.1118/1.1998541

DO - 10.1118/1.1998541

M3 - Article

AN - SCOPUS:85024810589

VL - 32

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -